N Latex FLC – new monoclonal high-performance assays for the determination of free light chain kappa and lambda

Autor: Ingrid Knop, Monic van den Broek, Hannie Klaasse Bos, Harald Althaus, Suzanne Hol, Brigitta Schmidt, Elisa Teunissen, Carola Wagner, Henk te Velthuis, Karin Schulte Fischedick, Roel Melsert, Peter Stam

Publikováno v: Clinical Chemistry and Laboratory Medicine (CCLM). 49:1323-1332

Background: High serum concentrations of monoclonal free light chain (FLC) kappa or lambda are markers of plasma cell dyscrasia. Methods: We developed new, latex-enhanced, specific nephelometric assays based on monoclonal antibodies for the determina

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f244c4b3198242f5755e3e85b6f29de
https://doi.org/10.1515/cclm.2011.624

Early Prediction of Nonprogression in Advanced Non-Small-Cell Lung Cancer Treated With Erlotinib By Using [(18)F]Fluorodeoxyglucose and [(18)F]Fluorothymidine Positron Emission Tomography

Autor: Reinhard Buettner, Lukas C. Heukamp, Walburga Engel-Riedel, Thomas Zander, Egbert Smit, Irini Papachristou, Roman K. Thomas, Andreas H. Jacobs, Markus Dietlein, Karin Toepelt, Adriaan Lammertsma, Andreas Draube, Martin Hellmich, Juergen Wolf, Erich Stoelben, Matthias Scheffler, Silvia Querings, Roland T. Ullrich, Karin Schulte, Yon D. Ko, Carsten Kobe, Ronald Boellaard, Lucia Nogova, Michael Hallek, Bernd Neumaier, Andreas Schlesinger

Publikováno v: Zander, T, Scheffler, M, Nogova, L, Kobe, C, Engel-Riedel, W, Hellmich, M, Papachristou, I, Toepelt, K, Draube, A, Heukamp, L, Buettner, R, Ko, Y D, Ullrich, R T, Smit, E F, Boellaard, R, Lammertsma, A A, Hallek, M, Jacobs, A H, Schlesinger, A, Schulte, K, Querings, S, Stoelben, E, Neumaier, B, Thomas, R K, Dietlein, M & Wolf, J 2011, ' Early Prediction of Nonprogression in Advanced Non-Small-Cell Lung Cancer Treated With Erlotinib By Using [(18)F]Fluorodeoxyglucose and [(18)F]Fluorothymidine Positron Emission Tomography ', Journal of Clinical Oncology, vol. 29, no. 13, pp. 1701-1708 . https://doi.org/10.1200/JCO.2010.32.4939
Journal of Clinical Oncology, 29(13), 1701-1708. American Society of Clinical Oncology

Purpose Positron emission tomography (PET) with both 2′-deoxy-2′-[18F]fluoro-d-glucose (FDG) and 3′-[18F]fluoro-3′-deoxy-l-thymidine (FLT) was evaluated with respect to the accuracy of early prediction of nonprogression following erlotinib th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9604a21f24ac1acffe8e95f2c96803f
https://research.vumc.nl/en/publications/e2fdda8e-54e6-4f9c-afef-31a344e84680